Skip to main content

Beneficial ownership — 13D / 13G

87,387 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Point72 Asset Management, L.P. FBRX Forte Biosciences, Inc. 13G/A 0% 6mo
VIKING GLOBAL INVESTORS LP PEPG PepGen Inc. 13G/A 5.03% 6mo
HIGHBRIDGE CAPITAL MANAGEMENT LLC KTWO K2 Capital Acquisition Corp 13G 8.8% 6mo
Solas Capital Management, LLC MAIA MAIA Biotechnology, Inc. 13G 7.1% 6mo
PERCEPTIVE ADVISORS LLC NVNO enVVeno Medical Corp 13G/A 9.99% 6mo
Sirenia Capital Management LP HELP Helus Pharma Inc. 13G 7.2% 6mo
ARMISTICE CAPITAL, LLC GCTK Glucotrack, Inc. 13G/A 4.99% 6mo
Berkshire Hathaway Inc DAL Delta Air Lines, Inc. 13G 6.1% 6mo
PRICE T ROWE ASSOCIATES INC /MD/ RMBS Rambus Inc 13G/A 3.1% 6mo
Ikarian Capital, LLC PTHS Pelthos Therapeutics Inc. 13G/A 7.7% 6mo
Contour Asset Management LLC ZETA Zeta Global Holdings Corp. 13G/A 2.3% 6mo
First Trust Capital Management L.P. TVA Texas Ventures Acquisition III Corp 13G/A 2.87% 6mo
Fort Baker Capital Management LP BCSS Bain Capital GSS Investment Corp. 13G/A 8.5% 6mo
First Trust Capital Management L.P. FMAC Future Money Acquisition Corp 13G 5.21% 6mo
WELLINGTON MANAGEMENT GROUP LLP EFSI Eagle Financial Services Inc 13G/A 5.2% 6mo
PRICE T ROWE ASSOCIATES INC /MD/ VICR Vicor Corp 13G 5.6% 6mo
LOCUST WOOD CAPITAL ADVISERS, LLC GPGI GPGI, Inc. 13G/A 4.8% 6mo
WELLINGTON MANAGEMENT GROUP LLP EE Excelerate Energy, Inc. 13G/A 8.2% 6mo
WELLINGTON MANAGEMENT GROUP LLP PFS Provident Financial Services Inc 13G/A 4.4% 6mo
Sirenia Capital Management LP ANAB Anaptysbio, Inc 13G 6.7% 6mo
PRICE T ROWE ASSOCIATES INC /MD/ VNOM Viper Energy, Inc. 13G/A 4.7% 6mo
Alyeska Investment Group, L.P. OM Outset Medical, Inc. 13G/A 0% 6mo
METEORA CAPITAL, LLC DBCA D. Boral Acquisition I Corp. 13G 6.88% 6mo
Rubric Capital Management LP NFE New Fortress Energy Inc. 13G/A 0% 6mo
Point72 Asset Management, L.P. PRAX Praxis Precision Medicines, Inc. 13G/A 0.2% 6mo
LAZARD ASSET MANAGEMENT LLC CAF Morgan Stanley China A Share Fund, Inc. 13G 11.5% 6mo
Greenhouse Funds LLLP VYX NCR Voyix Corp 13G/A 16.1% 6mo
WELLINGTON MANAGEMENT GROUP LLP DNOW DNOW Inc. 13G/A 9.1% 6mo
HARRIS ASSOCIATES L P CRBG Corebridge Financial, Inc. 13G 5.2% 6mo
METEORA CAPITAL, LLC JACS Jackson Acquisition Co II 13G 5.11% 6mo
Darwin Global Management, Ltd. INSM INSMED Inc 13G/A 7.8% 6mo
WELLINGTON MANAGEMENT GROUP LLP AAON Aaon, Inc. 13G/A 9.8% 6mo
HIGHBRIDGE CAPITAL MANAGEMENT LLC VCIC Vine Hill Capital Investment Corp. 13G/A 0% 6mo
Alger Associates, Inc. 13-3017981 ALAI Alger ETF Trust 13G/A 10.8% 6mo
COHEN & STEERS, INC. WELL Welltower Inc. 13G 5.18% 6mo
Lagoda Investment Management, L.P. VNRX Volitionrx Ltd 13G/A 10.7% 6mo
Durable Capital Partners LP CIGI Colliers International Group Inc. 13G/A 1.7% 6mo
ARMISTICE CAPITAL, LLC IRWD Ironwood Pharmaceuticals Inc 13G/A 9.22% 6mo
Fund 1 Investments, LLC JMIA Jumia Technologies AG 13G/A 9.95% 6mo
Venrock Healthcare Capital Partners III, L.P. CTMX CytomX Therapeutics, Inc. 13G/A 4.6% 6mo
MMCAP International Inc. SPC ARIS Aris Mining Corp 13G/A 3.8% 6mo
T. Rowe Price Investment Management, Inc. IMCR Immunocore Holdings plc 13G/A 3.7% 6mo
BIOTECHNOLOGY VALUE FUND L P AVTX Avalo Therapeutics, Inc. 13G/A 9.99% 6mo
WELLINGTON MANAGEMENT GROUP LLP POWI Power Integrations Inc 13G 6% 6mo
Garner Jennifer Anne OFRM Once Upon a Farm, PBC 13G 7.1% 6mo
Paradigm Biocapital Advisors LP EYPT EyePoint, Inc. 13G/A 3.8% 6mo
Westchester Capital Management, LLC OAKU Oak Woods Acquisition Corp 13G 9.92% 6mo
Bain Capital Life Sciences Fund II, L.P. XLO Xilio Therapeutics, Inc. 13G/A 9.99% 6mo
JANUS HENDERSON GROUP PLC LRN Stride, Inc. 13G 5.4% 6mo
AMERIPRISE FINANCIAL INC MTCH Match Group, Inc. 13G/A 5.7% 6mo